Transcept announces layoffs

Share this article:

Transcept Pharmaceuticals—known for its sleep drug Intermezzo—is cutting 43% of its workforce.

The company announced Tuesday that six employees will be laid off between now and early 2014, leaving a staff of eight.

The layoffs are part of a larger restructuring that includes reorganizing its board of directors.

The company's lead pipeline product, TO-2070, is for acute migraines.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.